Same here. I also wondered about it. I assumed RC or her subsidiary did it, though.
If anyone wants to do business, or research, with anatabine in the future, Anatabloc manufacturing facility is very important. Taking IP rights is one thing, actual manufacturing is another. Therefore, I argued that instead of taking only patents taking over the whole company (which includes manufacturing) by buying all the cheap shares and turning the company around is the better way. The bankruptcy court must be informed that the manufacturing facility alone should be able to fetch some not insignificant amount of money. It's only a wishful thinking of mine, though. By the way, I wonder if anyone is trying to find an alternative way to synthesize anatabine.
News 
Market Data 
Discover 
